Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Moodys
McKinsey
Baxter
Johnson and Johnson

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pyruvic acid

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Pyruvic acid?

Pyruvic acid is an investigational drug.

There have been 7 clinical trials for Pyruvic acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 15th 2017.

The most common disease conditions in clinical trials are Hepatitis B, Melanosis, and Hepatitis A. The leading clinical trial sponsors are Universidad Miguel Hernandez de Elche, University of Alicante, and Instituto de Salud Carlos III.

There are two hundred and sixty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Pyruvic acid
TitleSponsorPhase
Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic AcidAssiut UniversityPhase 4
Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate InjectionSunnybrook Health Sciences CentrePhase 1
Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar WartsIsfahan University of Medical SciencesPhase 2/Phase 3

See all Pyruvic acid clinical trials

Clinical Trial Summary for Pyruvic acid

Top disease conditions for Pyruvic acid
Top clinical trial sponsors for Pyruvic acid

See all Pyruvic acid clinical trials

US Patents for Pyruvic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyruvic acid   Start Trial Carbaphens: aprophen analogs that are binary antidotes for organophosphate poisoning The United States of America, as represented by the Secretary of the Army (Washington, DC)   Start Trial
Pyruvic acid   Start Trial Enzymatic process for preparing N-acetylneuraminic acid Forschungszentrum Juelich GmbH (Juelich, DE) Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
Pyruvic acid   Start Trial Insecticidal pyrazolines E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
Pyruvic acid   Start Trial Organic photochromic compound, a dimer of pyrido quinoline Seikisui Kagaku Kogyo Kabushiki Kaisha (JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyruvic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Pyruvic acid Austria 129016 2009-11-15   Start Trial
Pyruvic acid Australia 639035 2009-11-15   Start Trial
Pyruvic acid Australia 6587290 2009-11-15   Start Trial
Pyruvic acid Canada 2029984 2009-11-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Moodys
Johnson and Johnson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.